Executive Overview

In what industry analysts are already calling a milestone development for agricultural biosciences, agrochemical giant Syngenta has unveiled a radically new biological technology. Dubbed EXORT—short for EXOgenous RNA Targeting technology—the platform leverages naturally occurring plant microRNAs to optimize crop performance, boost yields, and enhance overall quality at remarkably low application rates.

According to Syngenta, EXORT represents the first entirely novel mode of action to enter the agricultural biologicals sector in more than two decades. Unlike traditional biostimulants or pest-control RNA solutions designed for gene silencing, EXORT acts cooperatively with a plant’s native biological signaling pathways. Serving as biological "dimmer switches," these naturally extracted microRNAs fine-tune a plant’s internal instructions before they reach its protein-building machinery.

Backed by an extensive four-year trial program spanning more than 15 countries and six major crops, the technology has consistently demonstrated yield improvements between 5% and 10%. Furthermore, because the initial microRNA signal is amplified by the plant’s own biological processes, the required application volume is exceptionally low—roughly 50 milligrams of active compound per hectare. This ultra-low dose profile promises sweeping logistical, financial, and environmental advantages, including dramatic reductions in packaging waste, transport weight, and warehousing demands. Syngenta plans to commercialize the first EXORT-based products in Latin America by 2027, marking the beginning of what the company hopes will be a transformative era for global crop production.

Detailed Chronology: From Genomics Bench to Global Field Trials

The development of EXORT did not happen overnight. It represents the culmination of years of convergence between advanced genomics, high-throughput bioinformatics, and precision plant science.

Phase I: Discovery and Algorithmic Screening (2022 and Prior)

The foundational work behind EXORT began with the recognition that microRNAs—tiny, non-coding RNA molecules naturally present in plants—play a vital role in regulating gene expression. While researchers have long understood that these molecules orchestrate developmental milestones such as grain growth, root proliferation, and fruit set, isolating and scaling them for agricultural applications presented an immense biochemical challenge.

To overcome this, Syngenta deployed sophisticated computational biology platforms. By combining massive genomic datasets with predictive modeling, researchers mapped out the universe of naturally occurring microRNAs associated with superior plant traits.

Candidates were algorithmically ranked based on:

• Biological relevance: Their direct correlation to traits like enhanced vigor, stress resilience, and reproductive efficiency.
• Target specificity: Ensuring the signals acted precisely on intended pathways without off-target systemic disruptions.
• Consistency: The predictability of the plant’s phenotypic response across diverse genetic lines.

Phase II: Global Field Testing (2022–2025)

Once the candidate microRNAs were extracted from natural plant-based raw materials, they underwent rigorous screening using high-throughput phenotyping. Extracts that produced repeatable, beneficial physical traits were advanced to controlled greenhouse trials and, ultimately, real-world field evaluations.

Between 2022 and 2025, Syngenta subjected EXORT formulations to an exhaustive validation campaign. The technology was tested across 240 distinct trials spanning over 15 countries. The testing matrix was exceptionally diverse, encompassing staple field crops—such as corn, soybeans, cotton, and rice—as well as specialized high-value fruits and vegetables.

Data gathered during this three-year window allowed agronomists to isolate the environmental parameters under which EXORT performs best. Trials revealed that the technology thrives when applied to actively growing foliage under optimal water-uptake conditions. Moreover, researchers mapped nuanced environmental dependencies: corn demonstrated heightened responsiveness under conditions of high rainfall and elevated relative humidity, whereas vegetable crops like tomatoes exhibited the strongest responses under moderate-to-low fertility or mild nutritional stress conditions.

Supporting Context & Metrics: Unpacking the Data Behind EXORT

The commercial viability of any new agricultural input hinges on hard data, robust economics, and logistical feasibility. Syngenta’s multi-year trials have provided a comprehensive dataset illuminating EXORT’s potential impact on farm economics and sustainability metrics.

Yield Gains and Crop-Specific Performance

Across the 240 trials conducted globally, treated crops consistently outperformed untreated control groups. Yield improvements universally hovered between 5% and 10%, depending on the geography, crop variety, and local pedoclimatic conditions.

In cereal production, the results were particularly eye-catching. Jerome Cassayre, Syngenta’s head of biologicals research, highlighted that rice trials recorded yield bumps of up to 740 kilograms per hectare. In row crops like corn and soybeans, the technology successfully influenced natural biological controls that typically cap grain growth inside the seed, effectively expanding the "sink capacity" of the plant to store energy and nutrients. Similarly, in fruiting vegetables, EXORT optimized the delicate transition from flowering to fruit set, reducing natural fruit drop and ensuring uniform, high-quality harvests.

The Power of Micro-Dosing: Efficiency at Scale

Perhaps the most disruptive aspect of the EXORT platform is its ultra-low application rate. Traditional liquid biostimulants often require heavy tank mixes, translating to high active-ingredient volumes per acre. EXORT, by contrast, operates on an entirely different scale.

Because the applied microRNAs act as catalysts that trigger amplification loops within the plant’s natural signaling cascades, microscopic quantities suffice. A standard application requires:

• Active Ingredient: Approximately 50 milligrams per hectare.
• Formulated Product: Around 100 grams per hectare.
• Application Method: Fully compatible with standard spray equipment and capable of being incorporated seamlessly into existing tank mixes.

Logistical and Environmental Footprint

The implications of a 50mg-per-hectare active ingredient rate extend far beyond the field, offering profound sustainability benefits along the supply chain. Syngenta estimates that compared to standard liquid biostimulant programs:

• Packaging Reduction: A single pallet of EXORT-based product can treat roughly 15 times as many hectares. This slashes plastic packaging requirements by approximately 99%.
• Storage and Warehousing: Warehousing and distribution volumes are reduced by up to 90% on a per-hectare basis.
• Transport Emissions: Haulage fuel consumption and logistics overheads for agricultural retailers and distributors drop commensurately, lowering the carbon footprint associated with input delivery.

Official Statements: Perspectives from Syngenta’s Leadership

The commercial and scientific significance of EXORT has been a focal point for Syngenta’s executive and research leadership, who emphasize that the platform bridges a long-standing gap between fundamental molecular biology and practical agronomy.

"What makes EXORT technology so exciting is that it translates a fundamental biological mechanism into a practical agricultural solution," noted Camilla Corsi, Syngenta’s Head of Crop Protection Research & Development. "Advances in genomics, bioinformatics, and plant science now allow us to identify and apply beneficial natural microRNAs with unprecedented precision."

Expounding on the biochemical uniqueness of the platform, Jerome Cassayre, Head of Biologicals Research, stressed that EXORT should not be conflated with traditional gene-silencing RNA tools designed for pest eradication.

"EXORT technology introduces a new class of active substances and is the first novel mode of action in biologicals in more than 20 years," Cassayre stated during an exclusive briefing with AgNavigator. "For the first time, we are able to select, extract, and deliver, at scale, naturally occurring plant microRNAs that act as biological signals already found in nature. Think of them as biological dimmer switches, fine-tuning instructions from a crop’s DNA before those instructions reach its protein-building machinery."

Crucially, Syngenta is taking deliberate steps to ensure growers understand that EXORT is designed to complement—rather than disrupt—current farming practices.

"Modern agriculture relies on an integrated toolbox of solutions, including crop protection products, biologicals, seeds, and digital technologies," Cassayre added. "EXORT adds a new mode of action by helping plants optimize their own natural processes, fitting cleanly into established spray routines without forcing farmers to overhaul their management programs."

Providing the commercial roadmap, Emilhano Lima, Global Head of Seedcare and Biologicals at Syngenta, underscored the universal applicability of the platform across diverse farming ecosystems.

"As a first-of-its-kind, natural microRNA-based biological technology, EXORT has the potential to deliver tangible value to farmers across a wide range of crops, geographies, and production systems," Lima remarked.

Future Outlook: Commercial Roadmap and Regulatory Horizons

As Syngenta transitions EXORT from the experimental phase to the commercial marketplace, all eyes are on the regulatory landscape and the timeline for deployment.

The company has confirmed that the global rollout will commence in Latin America in 2027. This initial launch will target a broad spectrum of agronomic systems, including extensive field crops as well as high-value fruit and vegetable operations. The products will be marketed both as standalone treatments and as synergistic additions to Syngenta’s existing seedcare, crop protection, and biological portfolios.

Navigating the Regulatory Landscape

Regulatory classification remains one of the most intriguing variables for the EXORT rollout. Because the active substances are naturally occurring plant extracts rather than synthetic chemistry or genetically modified organisms (GMOs), regulatory pathways will vary by jurisdiction.

Where established biostimulant frameworks already exist—such as in parts of Europe and South America—Syngenta intends to register EXORT formulations directly under biostimulant categories. In regions with less flexible or evolving definitions for RNA-based and natural-signal technologies, the company is actively engaging with regulatory bodies to establish clear, science-based evaluation standards. Industry observers expect that EXORT’s non-synthetic, plant-derived origin will streamline these discussions compared to synthetic molecules.

Beyond 2027: The Next Frontier in Crop Management

Looking further ahead, the successful commercialization of EXORT could open the floodgates for a completely new sub-discipline within agricultural biosciences. By proving that complex signaling molecules can be extracted, stabilized, and deployed at micro-doses in open-field conditions, Syngenta has established a technical blueprint that could be expanded to target other physiological traits—such as enhanced root architecture, accelerated nutrient use efficiency, or heightened tolerance to abiotic stressors like drought and heat.

For the modern grower facing mounting pressures from climate volatility, tightening profit margins, and increasingly stringent environmental regulations, technologies like EXORT offer a compelling value proposition. By working with the plant’s internal intelligence rather than imposing brute-force chemical interventions, Syngenta’s new platform points the way toward a more precise, sustainable, and productive future for global agriculture.